Mammoth Biosciences

Mammoth Biosciences is a pioneering biotechnology company based in Brisbane, California, dedicated to expanding the frontier of genetic medicine through its innovative CRISPR technology. Founded in 2017 by a diverse team comprising scientists, engineers, entrepreneurs, and thinkers, including renowned CRISPR co-inventor Jennifer Doudna, the company focuses on developing robust gene editing tools and diagnostic tests. Leveraging its proprietary ultracompact CRISPR systems, Mammoth aims to revolutionize diagnostic capabilities and create long-term curative therapies that can address a variety of genetic disorders.

The mission of Mammoth Biosciences is clear: to deliver on the full potential of genetic medicine. The company is committed to building out its pipeline of in vivo gene editing therapeutics and fostering partnerships with leading pharmaceutical and biotechnology firms to ensure that its groundbreaking technology can reach those in need. Its intellectual property portfolio is rich and diverse, which supports its invention and development of therapies that utilize CRISPR technology beyond traditional applications. This dedication to innovation is matched by a strong vision of improving global health, aligning with the belief that everyone should have access to advanced treatments and reliable diagnostics.